Press Releases

Date	Title
11/21/23	Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
11/15/23	Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
11/13/23	Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
11/10/23	UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
10/30/23	Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
10/24/23	Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
10/2/23	Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
9/29/23	Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
9/27/23	Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
9/7/23	Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase

Keyword Search